CBR Pharma InsightsCBR Pharma Insights (CBR) is an uppermost business intelligence provider for all participants of the pharmaceutical sector. The industry players seeking for professional advisories receive comprehensive support in developing their strategic initiatives as well as making quality business decisions.
Experienced pharm specialists and market analysts investigate the following market aspects:
- Market segments
- Current trends
- Regulatory policies within the industry
- Key players inside and outside the pharmaceutical sector
- Next-generation products
- Latest technologies
- Investment chances
- Distribution channels
- Consumer expectations and behaviors
For producers, we create a detailed product portfolio with the description of key end-user industries, product features and application regions.
All these findings are included in reports that help a client to comprehend favorable opportunities in developing business. Along with the growth factors overview, CBR offers to the customers the evaluation of their investment potential. CBR is focused on the strategic issues and helps an enterprise assess the possibility to enter a new market or strengthen their positions in their niche area.
CBR’s mission is to help a pharmaceutical company become more competitive on the national and global levels. We do it by providing a producer with exclusive product data and analysis and R&D solutions. As a result, a client is able to increase the efficiency of the production, launch new products and be a proactive player in the market.
We instruct customers on how to improve their production process and diversify the range of products.
Research Reports By CBR Pharma InsightsFound 24 publications
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players US$ 2,995.00 May, 2018 140 pages
Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 US$ 2,995.00 Mar, 2018 104 pages
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies US$ 2,995.00 Feb, 2018 106 pages
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis US$ 2,995.00 Jan, 2018 79 pages
Nutraceuticals: New Applications for Probiotics, Genetic Modification and Diet as Products Make Gains in Rx Territory US$ 2,995.00 Dec, 2017 49 pages
Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders US$ 2,995.00 Oct, 2017 72 pages
Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape US$ 2,995.00 Oct, 2017 57 pages
A Global Hyperhidrosis Market Landscape Assessment: Trends, Forecasts and Opportunities in a Growing Market US$ 2,995.00 Sep, 2017 63 pages
Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics US$ 2,995.00 Jul, 2017 78 pages
Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 US$ 2,995.00 Jun, 2017 67 pages
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline US$ 2,995.00 May, 2017 69 pages
Pharmaceutical Lifecycle Management Strategies in 2017 US$ 2,995.00 Apr, 2017 82 pages
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design US$ 2,995.00 Mar, 2017 117 pages
Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing US$ 2,995.00 Jan, 2017 63 pages
Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016 US$ 2,995.00 Dec, 2016 75 pages
Strategic Trends in Private Equity and Venture Capital Funding for Healthcare US$ 2,995.00 Nov, 2016 78 pages
Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period US$ 2,995.00 Nov, 2016 73 pages
The Future of Generic Drugs and Strategies for Commercial Success US$ 2,995.00 Sep, 2016 83 pages
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape US$ 2,995.00 Jul, 2016 46 pages
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline US$ 2,995.00 Jun, 2016 70 pages
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs US$ 2,995.00 May, 2016 60 pages
Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape US$ 2,995.00 Mar, 2016 73 pages
Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies US$ 2,995.00 Mar, 2016 64 pages
Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets US$ 2,995.00 Jan, 2016 86 pages
Skip to top